Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

UPC

Seven steps to UPC readiness

6 mai 2022
Briefing

par plusieurs auteurs

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

4 mars 2022

par Ross McNaughton et Adrian Toutoungi

Cliquer ici pour en savoir plus
Fusions et acquisitions d’entreprises et marchés financiers internationaux

Advising Placid0 on its acquisition by eyecare brand WALDO

25 février 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

Advising Nuclera on its Series B funding round

2 février 2022

par plusieurs auteurs

Cliquer ici pour en savoir plus